Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, June 14, 2025.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
Strong Downtrend (-100) - BCLI is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, BCLI continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid BCLI?
MarketClub looks at technical strength and momentum to determine if the timing is right for BCLI.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BCLI
The long-term trend has been DOWN since Aug 2nd, 2024 at 0.31
The intermediate-term trend has been DOWN since May 27th, 2025 at 1.05
The short-term trend has been DOWN since Jun 12th, 2025 at 1.18
Smart Scan Analysis for BCLI
Based on our trend formula, BCLI is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.170 | 1.175 | 1.080 | 1.100 | -0.080 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.100 | 238432 | 2025-06-13 15:58:02 |
| Year High | 5.35 | Year High Date | 2018-06-04 |
| Year Low | 2.88 | Year Low Date | 2018-02-09 |
| 52wk High | 8.085 | 52wk High Date | 2024-06-14 |
| 52wk Low | 0.7233 | 52wk Low Date | 2025-04-16 |
| Year End Close | 0.223 | Average Volume | 3,510,207 |
| Shares Outstanding | 7,939 | % Institutional | 19.6 |
| Market Cap | 91M | Assets | 3,571,000M |
| Liabilities | 11,028,000M | P/E Ratio | -0.94200000 |
| Beta | 0.8 | Volatility | 39.71 |